Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shirley M. Palmer"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:696-700
Ten patients were treated with conventional dosing (CD) and continuous-infusion (CI) vancomycin therapy in this prospective, randomized, crossover study. Patients were randomized to receive either CD or CI therapy for 2 consecutive days and then cros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b264cb1c13afb9e61b725fa1ea7c3fb
https://doi.org/10.1128/aac.40.3.696
https://doi.org/10.1128/aac.40.3.696
Publikováno v:
Antimicrobial Agents and Chemotherapy. 39:1797-1801
We compared the pharmacodynamics and killing activity of ceftazidime, administered by continuous infusion and intermittent bolus, against Pseudomonas aeruginosa ATCC 27853 and ceftazidime-resistant P. aeruginosa 27853CR with and without a single dail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2093ea4e4b7525dd3a319a4a64bdc85
https://doi.org/10.1128/aac.39.8.1797
https://doi.org/10.1128/aac.39.8.1797
Autor:
Shirley M. Palmer, Michael J. Rybak
Publikováno v:
American Journal of Health-System Pharmacy. 51:459-462
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7c3b00e1a4e935b2af60414b7e499f7
https://doi.org/10.1093/ajhp/51.4.459
https://doi.org/10.1093/ajhp/51.4.459
Autor:
Shirley M. Palmer, Ralph E. Small
Publikováno v:
American Pharmacy. 31:36-41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6abf105d78541c63a69f7410818da4
https://doi.org/10.1016/s0160-3450(16)33781-3
https://doi.org/10.1016/s0160-3450(16)33781-3
Publikováno v:
The Annals of pharmacotherapy. 33(5)
OBJECTIVE: To review the clinically significant antiinfectives approved by the Food and Drug Administration (FDA) since 1996, with an emphasis on agents used for treatment, prevention, or suppression of infection in immunocompromised individuals. DAT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbdc4f1d1cf0a685f39ccb9ec6ad872b
https://pubmed.ncbi.nlm.nih.gov/10369626
https://pubmed.ncbi.nlm.nih.gov/10369626
Autor:
Shirley M. Palmer, Michael J. Rybak
Publikováno v:
Antimicrobial agents and chemotherapy. 40(3)
We compared the pharmacodynamic activities of levofloxacin versus vancomycin, with or without rifampin, in an in vitro model with infected platelet-fibrin clots simulating vegetations. Infected platelet-fibrin clots were prepared with human cryopreci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc2c5c287b473410f53ae5250d4aad65
https://pubmed.ncbi.nlm.nih.gov/8851596
https://pubmed.ncbi.nlm.nih.gov/8851596
Cefepime (CP) is a new injectable cephalosporin with a broad spectrum of activity and stability against common chromosomally and plasmid-mediated beta-lactamases. The bactericidal activities of CP, ceftazidime (CZ), cefotaxime (CTX), and ceftriaxone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9697778156ae1eea6b851d887ce038a2
https://europepmc.org/articles/PMC162823/
https://europepmc.org/articles/PMC162823/
Autor:
Michael J. Rybak, Shirley M. Palmer
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 15:684-685
Vancomycin-resistant enterococci (VRE) are a major problem in numerous institutions in the United States. Most VRE are resistant to all available antimicrobial agents, resulting in serious therapeutic dilemmas. The resistance genes are transmitted on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b327da53597eadaed7d5b750ed8bd40
https://doi.org/10.1002/j.1875-9114.1995.tb02882.x
https://doi.org/10.1002/j.1875-9114.1995.tb02882.x